Cite
Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma.
MLA
Guo, Shengjie, et al. “Preoperative Serum Cystatin-C as a Potential Biomarker for Prognosis of Renal Cell Carcinoma.” PLoS ONE, vol. 12, no. 6, June 2017, pp. 1–18. EBSCOhost, https://doi.org/10.1371/journal.pone.0178823.
APA
Guo, S., Xue, Y., He, Q., He, X., Guo, K., Dong, P., Yao, K., Yang, G., Chen, D., Li, Z., Li, X., Qin, Z., Liu, Z., Cheng, W., Guo, C., Zhang, M., Han, H., & Zhou, F. (2017). Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma. PLoS ONE, 12(6), 1–18. https://doi.org/10.1371/journal.pone.0178823
Chicago
Guo, Shengjie, Yunfei Xue, Qiuming He, Xiaobo He, Kunbin Guo, Pei Dong, Kai Yao, et al. 2017. “Preoperative Serum Cystatin-C as a Potential Biomarker for Prognosis of Renal Cell Carcinoma.” PLoS ONE 12 (6): 1–18. doi:10.1371/journal.pone.0178823.